Open Access   Special Issue    Topic

Role of Transmembrane Mucins in Lung Diseases.

  • Special Issue Description
  • Keywords
  • Manuscript Submission information
  • Published Articles
  •   This special issue belongs to

      Research & Reviews : Journal of Medical Science and Technology

      Related section

       NA

      Deadline for Manuscript Submission

      March 31st, 2023

      Deadline for Publication

      April 15, 2023

    Special Issue Description


    Dear Collegues,



    Transmembrane mucins, such as Krebs von den Lungen-6/MUC1, MUC4, and MUC16, are particularly involved in the process of cellular proliferation, growth, and apoptosis and are expressed more prominently in damaged or regenerated epithelial cells.
    The study of the diagnostic and prognostic value of mucins in a variety of lung disorders, such as interstitial lung disease (ILD), lung cancer, and coronavirus disease, has recently attracted increased interest (COVID-19). Due to the inexorably worsening status of patients with concurrent interstitial lung involvement, this has brought attention to the significance of transmembrane mucins in rheumatologic illnesses linked with ILD and the need to detect individuals with lung involvement.
    Additionally, it has been hypothesized that mucins can be used to track the severity of disease since the coronavirus-2 pandemic that caused the severe acute respiratory syndrome outbreak.
    Original research articles, concise reports, and review articles concentrating on the function of transmembrane mucins in the area of lung ailments are requested for this topic.

    Keywords

    *Mucins *Lung Cancer *Rheumatology Diseases Associated with Pulmonary Involvement *COVID-19 *Interstitial lung diseases

    Manuscript Submission information


    Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
    Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.
    Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

    Published articles

    "This special issue is now open for submission."